Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndromeGrzegorz Helbig, Sławomira Kyrcz‐Krzemień, Magdalena Hałasz et al.|Medical Oncology|2011Cited by 28